← Back to Search
MDR3 P-glycoprotein, A Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs And Directly Interacts With Drugs As Judged By Interference With Nucleotide Trapping*
A. Smith, A. van Helvoort, G. van Meer, K. Szabó, E. Welker, G. Szakács, A. Váradi, B. Sarkadi, P. Borst
Published 2000 · Biology, Chemistry, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The human MDR3 gene is a member of the multidrug resistance (MDR) gene family. The MDR3 P-glycoprotein is a transmembrane protein that translocates phosphatidylcholine. The MDR1 P-glycoprotein related transports cytotoxic drugs. Its overexpression can make cells resistant to a variety of drugs. Attempts to show that MDR3 P-glycoprotein can cause MDR have been unsuccessful thus far. Here, we report an increased directional transport of several MDR1 P-glycoprotein substrates, such as digoxin, paclitaxel, and vinblastine, through polarized monolayers of MDR3-transfected cells. Transport of other good MDR1 P-glycoprotein substrates, including cyclosporin A and dexamethasone, was not detectably increased. MDR3 P-glycoprotein-dependent transport of a short-chain phosphatidylcholine analog and drugs was inhibited by several MDR reversal agents and other drugs, indicating an interaction between these compounds and MDR3 P-gp. Insect cell membranes from Sf9 cells overexpressing MDR3 showed specific MgATP binding and a vanadate-dependent,N-ethylmaleimide-sensitive nucleotide trapping activity, visualized by covalent binding with [α-32P]8-azido-ATP. Nucleotide trapping was (nearly) abolished by paclitaxel, vinblastine, and the MDR reversal agents verapamil, cyclosporin A, and PSC 833. We conclude that MDR3 P-glycoprotein can bind and transport a subset of MDR1 P-glycoprotein substrates. The rate of MDR3 P-glycoprotein-mediated transport is low for most drugs, explaining why this protein is not detectably involved in multidrug resistance. It remains possible, however, that drug binding to MDR3 P-glycoprotein could adversely affect phospholipid or toxin secretion under conditions of stress (e.g. in pregnant heterozygotes with oneMDR3 null allele).
This paper references
A rapid method of total lipid extraction and purification.
E. G. Bligh (1959)
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
C. Chen (1986)
The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver.
A. M. van der Bliek (1987)
Sequence of mdr3 cDNA encoding a human P-glycoprotein.
A. M. van der Bliek (1988)
Genes amplified and overexpressed in human multidrug-resistant cell lines.
A. M. van der Bliek (1988)
Cloning and characterization of a second member of the mouse mdr gene family.
P. Gros (1988)
Multidrug resistance in cancer.
N. Kartner (1989)
Expression of the human multidrug transporter in insect cells by a recombinant baculovirus.
U. Germann (1990)
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
E. Georges (1990)
Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
H. Herweijer (1990)
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter.
Shoichiro Tanaka (1990)
Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
M. Raymond (1990)
Expression of the mdr3 gene in prolymphocytic leukemia: Association with cyclosporin‐a‐induced increase in drug accumulation
K. Nooter (1990)
Structure of the human MDR3 gene and physical mapping of the human MDR locus.
C. Lincke (1991)
Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
A. Schinkel (1991)
Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.
E. Buschman (1991)
Reduced mRNA levels for the multidrug‐resistance genes in cAMP‐dependent protein kinase mutant cell lines
K. Chin (1992)
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
K. Ueda (1992)
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.
B. Sarkadi (1992)
Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Y. Tanigawara (1992)
Contribution of MDR3 P-gp to Transport of Cytotoxic Drugs
Y. Tanigawara (1992)
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
J.J.M. Smit (1993)
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
A. Schinkel (1993)
A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?
S. Ruetz (1994)
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.
T. H. Mauad (1994)
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
S. Ruetz (1994)
Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase.
A. van Helvoort (1994)
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
G. Zaman (1994)
The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
Alexander J. Smith (1994)
The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
E. Buschman (1994)
P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*)
I. Urbatsch (1995)
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
A. Schinkel (1995)
Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate
S. Ruetz (1995)
Differential targeting of glucosylceramide and galactosylceramide analogues after synthesis but not during transcytosis in Madin-Darby canine kidney cells.
I. L. V. Genderen (1995)
Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active (*)
I. Urbatsch (1995)
Genetic analysis of the multidrug transporter.
M. Gottesman (1995)
MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
A. V. Helvoort (1996)
Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P‐glycoproteins
Kouichi Kino (1996)
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
U. Germann (1996)
Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.
R. Evers (1996)
Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells
P. van der Bijl (1996)
Multidrug Resistance of Cancer Cells
S. Kane (1996)
Control analysis of biliary lipid secretion.
A. Groen (1996)
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
A. Schinkel (1997)
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
U. Mayer (1997)
Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.
A. Crawford (1997)
Drug-stimulated Nucleotide Trapping in the Human Multidrug Transporter MDR1
K. Szabó (1998)
Availability of PSC833, a Substrate and Inhibitor of P-glycoproteins, in Various Concentrations of Serum
A. Smith (1998)
Hepatocyte‐specific expression of the human MDR3P‐glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (−/−) mice
Alexander J. Smith (1998)
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
J. M. de Vree (1998)
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
E. Jacquemin (1999)
The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane.
R. Raggers (1999)
This paper is referenced by
Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3
T. Kroll (2021)
CRISPR/Cas9 mutagenesis reveals a role for ABCB1 in gut immune responses to Vibrio diazotrophicus in sea urchin larvae.
Travis J Fleming (2021)
Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4.
Martin Prescher (2021)
Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.
J. Beaudoin (2020)
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
A. Stättermayer (2020)
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4−/− mouse model of PFIC3
Guangyan Wei (2020)
Looking back at multidrug resistance (MDR) research and ten mistakes to be avoided when writing about ABC transporters in MDR
P. Borst (2020)
ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine
Martin Prescher (2019)
Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells
Kyoko Tanaka (2019)
Structure of the human lipid exporter ABCB4 in a lipid environment
J. A. Olsen (2019)
What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs
O. Briz (2019)
ABCB4 disease: Many faces of one gene deficiency.
E. Sticova (2019)
Structure and Function of Multidrug Resistance Protein 1
E. N. Yakusheva (2018)
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro
Jia-feng Huang (2018)
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
M. Reichert (2018)
Transporters in Hepatotoxicity
Eleni Kotsampasakou (2018)
Models for drug absorption from the small intestine: where are we and where are we going?
Pierre-André Billat (2017)
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
S. Dewanjee (2017)
Upregulating Nrf2-dependent antioxidant defenses in Pacific oysters Crassostrea gigas: Investigating the Nrf2/Keap1 pathway in bivalves.
N. M. Danielli (2017)
Reversal effects of local anesthetics on P-glycoprotein-mediated cancer multidrug resistance
Yong Hu (2017)
UvA-DARE ( Digital Academic Repository ) ABC transporters in Arthropods : genomic comparison and role in insecticide transport and resistance
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations
M. Cardoso (2017)
Down-regulation of ABCG2 and ABCB4 transporters in the placenta of rats exposed to cadmium
L. Liu (2016)
Role of MDR3 in drug-induced cholestatic liver injury
Z. Mahdi (2016)
Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis
Z. Mahdi (2016)
ATP-binding cassette transporters in reproduction: a new frontier.
E. Bloise (2016)
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
F. Aminkeng (2016)
Maternal-fetal transfer of indocyanine green across the perfused human placenta.
Miriam Rubinchik-Stern (2016)
Hepatotoxicidad: patrón colestásico inducido por fármacos Hepatotoxicity: A Drug-Induced Cholestatic Pattern
Laura Morales (2016)
Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3
H. J. Park (2016)
Hepatotoxicity : A Drug-Induced Cholestatic Pattern
L. Morales (2016)
Position 834 in TM6 plays an important role in cholesterol and phosphatidylcholine transport by ABCA1
Shimpei Itoh (2015)See more